Perkinelmer Inc. is a provider of technology, services and solutions to the diagnostics, detection and analysis and photonics markets. It designs, manufactures and services components, systems and products in two segments: Life and Analytical Sciences, and Optoelectronics. The health sciences markets include all of the businesses in the Company’s Life and Analytical Sciences segment and the medical imaging business, as well as elements of the medical sensors and lighting businesses in its Optoelectronics segment. The photonics markets include the remaining businesses in its Optoelectronics segment. It markets its products and services in more than 150 countries. In March 2008, the Company acquired LabMetrix Technologies, a provider of metrology-based, multi-vendor analytical instrument qualification solutions. In May 2008, it announced the expansion of its health and environmental focus to India with the opening of a global EcoAnalytix application and technical center in Mumbai.
MDS Inc. is a life sciences company that provides products and services that its customers need for the development of drugs and the diagnosis and treatment of disease. The Company is a provider of pharmaceutical research services, medical isotopes for molecular imaging, sterilization, radiotherapeutics and analytical instruments. MDS operates in three business units within the life sciences industry: MDS Pharma Services; MDS Nordion, and MDS Analytical Technologies. The Company operates under three business units: MDS Pharma Services, MDS Nordion and MDS Analytical Technologies. On February 26, 2007, the Company sold its remaining Canadian diagnostics businesses to Borealis Infrastructure Management Inc. On March 20, 2007, the Company acquired Molecular Devices Corporation. In June 2008, the Company’s unit, MDS Analytical Technologies, acquired Blueshift Biotechnologies.
Bio-Rad Laboratories, Inc. (Bio-Rad) manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a range of products and systems used to separate chemical and biological materials, and to identify, analyze and purify their components. Bio-Rad operates in two industry segments: Life Science and Clinical Diagnostics. Both segments operate worldwide. On October 1, 2007, the Company acquired approximately 85.96% of the outstanding shares of DiaMed, a private Swiss company. (Source: 10-K)
Privacy Policy | Terms and Conditions | Do Not Sell My Personal Information | Websites Directory
Copyright © 2022 kwtbox.com. All Rights Reserved. US Business Directory